Open Access
ARTICLE
Bo Ling, Zuliang Huang, Suoyi Huang, Li Qian, Genliang Li, Qianli Tang
Oncology Research, Vol.28, No.6, pp. 561-578, 2020, DOI:10.3727/096504020X15907428281601
Abstract There is growing evidence on the clinical significance of tumor microenvironment (TME) cells in predicting prognosis and therapeutic effects. However, cell interactions in tumor microenvironments have not been
thoroughly studied or systematically analyzed so far. In this study, 22 immune cell components in the lung
adenocarcinoma (LUAD) TME were analyzed using gene expression profile from The Cancer Genome Atlas
(TCGA) and Gene Expression Omnibus (GEO). The TME-based molecular subtypes of LUAD were defined
to evaluate further the relationship between molecular subtypes, prognosis, and clinical characteristics. A TME
risk score model was constructed by using the differentially expressed genes (DEGs) of… More >
Open Access
ARTICLE
Lili Deng*1, Xue Yang†1, Jun Fan*, Yuedi Ding*, Ying Peng*, Dong Xu*, Biao Huang*‡, Zhigang Hu†
Oncology Research, Vol.28, No.6, pp. 579-590, 2020, DOI:10.3727/096504020X15942028641011
Abstract Colorectal cancer is an aggressive malignancy for which there are limited treatment options. Oncolytic vaccinia
virus is being developed as a novel strategy for cancer therapy. Arming vaccinia virus with immunostimulatory
cytokines can enhance the tumor cell-specific replication and antitumor efficacy. Interleukin-24 (IL-24) is an
important immune mediator, as well as a broad-spectrum tumor suppressor. We constructed a targeted vaccinia
virus of Guang9 strain harboring IL-24 (VG9-IL-24) to evaluate its antitumor effects. In vitro, VG9-IL-24
induced an increased number of apoptotic cells and blocked colorectal cancer cells in the G2
/M phase of the
cell cycle. VG9-IL-24 induced apoptosis in… More >
Open Access
ARTICLE
Hengzhou Lin, Dahui Zuo, Jiabin He, Tao Ji, Jianzhong Wang, Taipeng Jiang
Oncology Research, Vol.28, No.6, pp. 591-603, 2020, DOI:10.3727/096504020X15982623243955
Abstract The long noncoding RNA WEE2 antisense RNA 1 (WEE2-AS1) plays an oncogenic role in hepatocellular
carcinoma and triple negative breast cancer progression. In this study, we investigated the expression and roles
of WEE2-AS1 in glioblastoma (GBM). Furthermore, the molecular mechanisms behind the oncogenic actions
of WEE2-AS1 in GBM cells were explored in detail. WEE2-AS1 expression was detected using quantitative
real-time polymerase chain reaction. The roles of WEE2-AS1 in GBM cells were evaluated by the cell counting kit-8 assay, flow cytometric analysis, Transwell cell migration and invasion assays, and tumor xenograft
experiments. WEE2-AS1 expression was evidently enhanced in GBM tissues and… More >
Open Access
ARTICLE
Piao Yongfeng*†‡§1, Jiang Chuner*¶#1, Wang Lei*†‡§, Yan Fengqin*†‡§, Ye Zhimin*†‡§, Fu Zhenfu*†‡§, Jiang Haitao*,**††, Jiang Yangming‡‡, Wang Fangzheng*†‡§
Oncology Research, Vol.28, No.6, pp. 605-613, 2020, DOI:10.3727/096504020X16022401878096
Abstract The aim of this study was to explore the predictive role of pretreatment MRI-based radiomics on early response
of neoadjuvant chemotherapy (NAC) in locoregionally advanced nasopharyngeal carcinoma (NPC) patients.
Between January 2016 and December 2016, a total of 108 newly diagnosed NPC patients who were hospitalized in the Cancer Hospital of the University of Chinese Academy of Sciences were reviewed. All patients
had complete data of enhanced MR of nasopharynx before treatment, and then received two to three cycles of
TP-based NAC. After 2 cycles of NAC, enhanced MR of nasopharynx was conducted again. Compared with
the enhanced MR images… More >
Open Access
ARTICLE
WM Farhan Syafiq B. WM Nor*†, Ivy Chung‡§, Nur Akmarina B. M. Said†
Oncology Research, Vol.28, No.6, pp. 615-629, 2020, DOI:10.3727/096504020X16037933185170
Abstract Breast cancer is the most commonly diagnosed cancer among women and one of the leading causes of cancer
mortality worldwide, in which the most severe form happens when it metastasizes to other regions of the body.
Metastasis is responsible for most treatment failures in advanced breast cancer. Epithelial–mesenchymal transition (EMT) plays a significant role in promoting metastatic processes in breast cancer. MicroRNAs (miRNAs)
are highly conserved endogenous short noncoding RNAs that play a role in regulating a broad range of biological processes, including cancer initiation and development, by functioning as tumor promoters or tumor suppressors. Expression of miR-548m has been… More >
Open Access
ARTICLE
Andrea Lapucci*†1, Gabriele Perrone*†1, Antonello Di Paolo‡§, Cristina Napoli*†, Ida Landini*†,
Giandomenico Roviello*†, Laura Calosi¶, Antonio Giuseppe Naccarato#, Alfredo Falcone#, Daniele Bani¶, Enrico Mini*†§2, Stefania Nobili*†§2,3
Oncology Research, Vol.28, No.6, pp. 631-644, 2020, DOI:10.3727/096504020X16056983169118
Abstract The benefit of adjuvant chemotherapy in the early stages of colorectal cancer (CRC) is still disappointing and
the prediction of treatment outcome quite difficult. Recently, through a transcriptomic approach, we evidenced
a role of PNN and KCNQ1OT1 gene expression in predicting response to fluoropyrimidine-based adjuvant
chemotherapy in stage III CRC patients. Thus, the aim of this study was to validate in an independent cohort of
stages II–III CRC patients our previous findings. PNN and KCNQ1OT1 mRNA expression levels were evaluated in 74 formalin-fixed paraffin-embedded tumor and matched normal mucosa samples obtained by stages
II–III CRC patients treated with fluoropyrimidine-based adjuvant… More >
Open Access
ARTICLE
Linn Woelber*1, Sabrina Mathey*1, Katharina Prieske*†, Sascha Kuerti*, Christoph Hillen*, Eike Burandt‡,
Anja Coym§, Volkmar Mueller*, Barbara Schmalfeldt*, Anna Jaeger*
Oncology Research, Vol.28, No.6, pp. 645-659, 2020, DOI:10.3727/096504020X16076861118243
Abstract Therapeutic options in recurrent or metastasized vulvar squamous cell cancer (VSCC) not amenable to radiotherapy or radical surgery are limited. Evidence for the use of targeted therapies is sparse. All patients with
VSCC treated at the Gynecological Cancer Center Hamburg-Eppendorf 2013–2019 were retrospectively evaluated for targeted therapeutic approaches. Furthermore, a MEDLINE, EMBASE, Web of Science, Scopus,
and OVID database search was performed using the terms: “vulvar cancer” AND “targeted therapy,” “erlotinib,” “EGFR,” “bevacizumab,” “VEGF,” “pembrolizumab,” or “immunotherapy.” Twelve of 291 patients
(4.1%) with VSCC received at least one targeted therapy at our institution. Previously, one or more platinumbased chemotherapy was… More >
Open Access
REVIEW
Yu Sun, Wei Wang, Chenghai Zhao
Oncology Research, Vol.28, No.6, pp. 661-674, 2020, DOI:10.3727/096504020X16014648664459
Abstract Wnt molecules play crucial roles in development and adult homeostasis through their receptors Frizzled proteins
(Fzds). Fzds mediate canonical b-catenin pathway and various noncanonical b-catenin-independent pathways.
Aberrant Fzd signaling is involved in many diseases including cancer. Wnt/b-catenin is a well-established oncogenic pathway involved in almost every aspect of tumor development. However, Fzd-mediated noncanonical Wnt
pathways function as both tumor promoters and tumor suppressors depending on cellular context. Fzd-targeted
therapies have proven to be effective on cultured tumor cells, tumor cell xenografts, mouse tumor models, and
patient-derived xenografts (PDX). Moreover, Fzd-targeted therapies synergize with chemotherapy in preclinical
models. However, the occurrence… More >
Open Access
ERRATUM
Chang Li*, Shuohui Gao*, Xiaoping Li†, Chang Li‡, Lianjun Ma§
Oncology Research, Vol.28, No.6, pp. 675-679, 2020, DOI:10.3727/096504021X16137463165406
Abstract Colon cancer is one of the most lethal varieties of cancer. Chemotherapy remains as one of the principal
treatment approaches for colon cancer. The anticancer activity of procaine (PCA), which is a local anesthetic
drug, has been explored in different studies. In our study, we aimed to explore the anticancer effect of PCA on
colon cancer and its underlying mechanism. The results showed that PCA significantly inhibited cell viability,
increased the percentage of apoptotic cells, and decreased the expression level of RhoA in HCT116 cells in a
dose-dependent manner (p < 0.05 or p < 0.01). Moreover, PCA increased the… More >
Open Access
ERRATUM
Juan Gu*, Chang-fu Cui†, Li Yang‡, Ling Wang*, Xue-hua Jiang*
Oncology Research, Vol.28, No.6, pp. 681-682, 2020, DOI:10.3727/096504021X16137463165424
Abstract Colon cancer (CC) is the third most common cancer worldwide. Emodin is an anthraquinone-active substance that has the ability to affect tumor progression. Our study aims to explore the effects and the relevant
mechanism of emodin on the invasion and migration of CC in vitro and in vivo. In our study, we found that
emodin inhibited the invasion and migration abilities of RKO cells and decreased the expression of matrix
metalloproteinase-7 (MMP-7), MMP-9, and vascular endothelial growth factor (VEGF) in a dose-dependent
manner. Further research suggested that emodin inhibited EMT by increasing the mRNA level of E-cadherin
and decreasing the… More >
Open Access
ERRATUM
Yang Sun*1, Jun-Gong Jin*1, Wei-Yang Mi†, Hao-Wu*, Shi-Rong Zhang‡, Qiang Meng*, Shi-Tao Zhang‡
Oncology Research, Vol.28, No.6, pp. 683-684, 2020, DOI:10.3727/096504021X16137463165433
Abstract Glioma is the most common and lethal malignant intracranial tumor. Long noncoding RNAs (lncRNAs) have
been identified as pivotal regulators in the tumorigenesis of glioma. However, the role of lncRNA urothelial
carcinoma-associated 1 (UCA1) in glioma genesis is still unknown. The purpose of this study was to investigate the underlying function of UCA1 on glioma genesis. The results demonstrated that UCA1 was upregulated
in glioma tissue and indicated a poor prognosis. UCA1 knockdown induced by si-UCA1 significantly suppressed the proliferative, migrative, and invasive activities of glioma cell lines (U87 and U251). Bioinformatics
analysis and luciferase reporter assay verified the complementary… More >
Login
Register
Submit a Paper
Propose a Special lssue